HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N-benzylcantharidinamide

an MMP-9 inhibitor; structure in first source

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzofurans: 26
      - Cantharidin: 597
        N-benzylcantharidinamide: 1
Organic Chemicals: 133
- Imides: 79
  - N-benzylcantharidinamide: 1

Experts

1.	Choi, Hee-Jung: 1 article (05/2014)
2.	Choi, Jun-Yong: 1 article (05/2014)
3.	Chung, Tae-Wook: 1 article (05/2014)
4.	Eun, Jae Soon: 1 article (05/2014)
5.	Ha, Ki-Tae: 1 article (05/2014)
6.	Han, Chang-Woo: 1 article (05/2014)
7.	Han, Young Taek: 1 article (05/2014)
8.	Jeong, Han-Sol: 1 article (05/2014)
9.	Kim, So-Yeon: 1 article (05/2014)
10.	Lee, Chang Hyun: 1 article (05/2014)

Related Diseases

1.	Hepatocellular Carcinoma (Hepatoma) 05/02/2014 - "The present study aimed to investigate the molecular events underlying inhibitory effect of N-benzylcantharidinamide, a novel synthetic analog of cantharidin, on matrix metalloproteinase-9 (MMP-9)-mediated invasion in highly metastatic hepatocellular carcinoma Hep3B cells. "

Related Drugs and Biologics

1.	Matrix Metalloproteinase 9 (Gelatinase B)
2.	Cantharidin (Cantharides)